![Armend G. Håti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Armend G.
Håti is the founder of Nordovo Biosciences AS and currently holds the title of Chief Executive Officer.
Posizioni attive di Armend G. Håti
Società | Posizione | Inizio |
---|---|---|
Nordovo Biosciences AS
![]() Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Amministratore Delegato | 01/01/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Nordovo Biosciences AS
![]() Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Armend G. Håti